Industry
Pharmaceutical Industry
Independent audit, assurance and regulatory consulting for pharmaceutical manufacturers, covering GMP compliance, supplier qualification, inspection readiness and quality system improvement across EU, UK, US and India regulatory frameworks.
The Regulatory Environment
Pharmaceutical manufacturers operate within one of the most comprehensively regulated environments in any industry. EU GMP, FDA CGMP, ICH Q-series guidelines, national competent authority requirements and a continuously evolving compliance landscape create a regulatory burden that requires sustained, expert-level quality management to navigate effectively.
The regulatory consequences of GMP non-compliance are severe: import alerts, manufacturing shutdown orders, product recalls and marketing authorisation suspensions are all documented outcomes of significant inspection findings. The cost of these consequences, in remediation, business disruption and reputational damage, is substantially higher than the cost of maintaining effective quality systems and conducting independent audit programmes.
Sthira Assure supports pharmaceutical organisations in maintaining GMP compliance through independent audit, supplier qualification and quality system consulting. We combine direct experience of regulatory inspection practices across EU and US frameworks with the sector-specific knowledge that effective pharmaceutical quality assurance requires.
Key Regulatory Frameworks
- EU GMP Parts I & II
- FDA 21 CFR 210/211
- ICH Q7, Q8, Q9, Q10
- GDP Guidelines
- WHO GMP
- PIC/S
Typical Risk Areas
Manufacturing Process Validation
Process validation remains a high-priority inspection area for both EMA and FDA. Organisations must demonstrate that manufacturing processes are validated to deliver consistently safe and effective products. Inspectors assess whether validation studies are comprehensive, whether acceptance criteria reflect regulatory expectations and whether the validation programme covers the full lifecycle of the process.
API Supplier Oversight
The pharmaceutical supply chain is heavily dependent on API manufacturers concentrated in a small number of jurisdictions. Pharmaceutical companies remain legally responsible for the quality of APIs used in their products regardless of how many layers of supply chain separate them from API manufacture. Independent API supplier audits are a regulatory expectation, not an option.
Data Integrity in QC Laboratories
Quality control laboratory data integrity is consistently among the leading causes of FDA warning letters and MHRA inspection findings. From chromatography system audit trails to laboratory notebooks and LIMS records, inspectors look for evidence that data cannot be manipulated and that all test results, including failures, are documented and assessed.
Change Control and Variation Management
Post-approval changes to manufacturing processes, specifications and site operations require regulatory notification and sometimes approval before implementation. Many organisations manage change control processes inadequately, implementing changes without full regulatory assessment and introducing undisclosed variations that inspectors identify through batch record review.
Speak with a Pharmaceutical Compliance Specialist
Contact our team to discuss your pharmaceutical compliance requirements and audit programme.